Gastroenterology – Medxy AI

Sequential Lactulose and TeleTai-Chi to Prevent Falls in Cirrhosis: Insights from the LiveSMART Trial

By MedXY 09/21/2026

The LiveSMART trial demonstrates that lactulose, with or without sequential TeleTai-Chi, significantly reduces fall risk and related harms in cirrhotic patients without prior overt hepatic encephalopathy.

Gastroenterology news Oncology

Dynamic Gut Microbiome Changes Enhance Immunotherapy Outcomes in Advanced Liver Cancer

By MedXY 09/21/2026

This longitudinal study reveals that gut microbiome remodeling during immune checkpoint inhibitor therapy in advanced liver cancer patients predicts clinical benefit, improving biomarker accuracy and survival stratification.

Gastroenterology Internal Medicine news

Evaluating Non-Enteric-Coated Pancreatic Enzyme Therapy for Pain Relief in Chronic Pancreatitis: Insights from a Robust Randomized Trial

By MedXY 09/21/2026

A recent double-blind, placebo-controlled trial found that non-enteric-coated pancreatic enzyme therapy does not significantly reduce pain in chronic pancreatitis patients, highlighting the need to revisit pain management strategies in this condition.

Gastroenterology General Surgery news

Xenotransplantation in Acute Liver Failure: Bridging the Organ Gap with Genetically Modified Porcine Livers

By MedXY 09/20/2026

This article reviews advances in liver xenotransplantation using genetically modified porcine organs as a bridging strategy for acute liver failure, highlighting recent clinical progress, challenges, and future directions.

Gastroenterology Infectious Diseases news

Dissecting Gut-Vascular Barrier Failures: Macrophage Dysfunction Drives Bacterial Translocation in Cirrhosis

By MedXY 09/20/2026

This study elucidates how intestinal blood vessel-associated macrophage dysfunction contributes to gut-vascular barrier breakdown and bacterial translocation in cirrhosis, revealing novel mechanisms that underlie systemic infection risks in liver disease.

Gastroenterology General Surgery news

Out-of-Hours Liver Transplantation: Identifying High-Risk Timeframes and Implications for Patient Outcomes

By MedXY 09/19/2026

A Swedish national retrospective study reveals that liver transplantations initiated between 17:00 and 05:59 are linked to significantly increased postoperative complications and healthcare costs, highlighting the need for optimized scheduling.

Gastroenterology Internal Medicine news

VPS13D: A Crucial Regulator of Organelle Contact Sites and Lipid Metabolism in Alcohol-Associated Steatohepatitis

By MedXY 09/19/2026

VPS13D protects against alcohol-induced liver injury by maintaining mitochondria-ER contact sites, regulating phospholipid balance and promoting VLDL secretion, thus mitigating steatosis and inflammation in alcoholic hepatitis.

Allergy & Immunology Gastroenterology news

Unveiling the TL1A-LTα1β2/IL-22 Axis: A New Therapeutic Target in Crohn’s Disease with Perianal Fistulising Disease

By MedXY 09/19/2026

This study reveals that TL1A-activated CD4+ T cells drive distinct cellular and molecular changes in the rectal mucosa of Crohn's disease patients with perianal fistulising disease (PFD), highlighting a novel TL1A-LTα1β2/IL-22 axis independent of TNF signaling, with important therapeutic implications.

Gastroenterology General Surgery news

Balancing Safety and Recurrence: Cold vs Hot Snare Resection of Large Colorectal Polyps

By MedXY 09/19/2026

This meta-analysis of four RCTs compares cold and hot snare polypectomy for large colorectal polyps, demonstrating lower major adverse events but higher recurrence with cold resection, especially in adenomas with high-grade dysplasia.

Gastroenterology news Oncology

Rising Early-Onset Colorectal Cancer and Persistent Racial Disparities Despite Increased Colonoscopy Use

By MedXY 09/18/2026

From 2017 to 2023, colonoscopy use increased notably in adults under 50. Yet, early-onset colorectal cancer rates and racial disparities, particularly among Black and Hispanic populations, worsened, highlighting that screening alone does not resolve these inequities.

Gastroenterology General Surgery news

Integrative Muscle-Adipose Score (IMAS): Enhancing Sex-Sensitive Prognostication After Liver Transplantation

By MedXY 09/18/2026

The Integrative Muscle-Adipose Score (IMAS) combines muscle and fat measures into a sex-specific tool that accurately predicts long-term survival and postoperative complications in liver transplant recipients, outperforming existing models.

Gastroenterology Neurology news

Harnessing Kynurenic Acid and the Gut-Brain Axis to Improve Stroke Recovery

By MedXY 09/18/2026

Kynurenic acid (KYNA) reduction in the gut correlates with worse poststroke outcomes. Supplementation activates a gut-brain neural circuit via GPR35 and the vagus nerve, promoting neuroprotection and functional recovery after ischemic stroke.

Gastroenterology news Public Health

Parental Obesity and the Adult Offspring’s Risk of Metabolic Dysfunction Associated Steatotic Liver Disease: Insights from a UK Birth Cohort Study

By MedXY 09/17/2026

This UK cohort study reveals that both maternal and paternal obesity before pregnancy significantly increase offspring's risk of metabolic dysfunction associated steatotic liver disease (MASLD) by age 24, largely mediated by excess childhood adiposity.

Cardiology Gastroenterology news

Intestinal Serotonergic Vagal Signaling: A Novel Link Between Gut Microbiota and Hypertension Management

By MedXY 09/17/2026

Recent research identifies intestinal serotonin 5-HT3a receptor signaling via vagal neurons as a key mediator of microbiota-induced hypertension, offering new insights into resistant hypertension and potential therapeutic targets.

Gastroenterology news Oncology

New International Consensus: Colorectal Cancer Risk in MASLD — What Clinicians Need to Know

By MedXY 09/15/2026

An international Delphi panel concludes metabolic dysfunction‑associated steatotic liver disease (MASLD) raises colorectal cancer (CRC) risk. Experts call for earlier, risk‑adapted CRC screening and integrated metabolic care to reduce CRC burden in patients with MASLD.

Gastroenterology news Public Health

Global Burden of Disorders of Gut-Brain Interaction: Insights from Rome V Versus Rome IV Criteria

By MedXY 09/15/2026

The Rome V global epidemiology survey confirms a high prevalence of disorders of gut-brain interaction (DGBI) worldwide, consistent with prior Rome IV findings, underscoring a significant and persistent global clinical burden.

Diabetes & Endocrinology Gastroenterology news

Differential Gastrointestinal Risks of Opioids in Type 2 Diabetes Patients on GLP-1RA Therapy: A Comparative Analysis

By MedXY 09/15/2026

Among type 2 diabetes patients using GLP-1 receptor agonists, oxycodone is linked to higher short-term risks of severe gastrointestinal complications compared to hydrocodone and tramadol, warranting cautious opioid selection in this population.

Cardiology Gastroenterology news

Subclinical Liver Disease as a Silent Driver of Cardiovascular Risk: Insights from a Large-Scale Prospective Study

By MedXY 09/15/2026

Subclinical liver disease, marked by steatosis, fibrosis, and functional impairment, independently and synergistically increases cardiovascular disease risk. Incorporating non-invasive liver biomarkers could enhance CVD risk prediction and inform prevention strategies.

Gastroenterology news Oncology

Mapping Liver Cancer’s Hidden Frontiers: NCACC Uncovers Rare cIgG+ Epithelial Cells Driving Tumor Invasion

By MedXY 09/14/2026

NCACC technology identifies rare cIgG+ epithelial cells at liver cancer invasive fronts, revealing a STAT1-dependent signaling axis promoting aggressiveness and offering new therapeutic targets in liver cancer.

Gastroenterology news Oncology

Germline MSH3 and MLH3 Mutations as Tumor Suppressors Elevating Colorectal Cancer Risk via Hypermutation Signature ID4

By MedXY 09/14/2026

Heterozygous germline mutations in MSH3 and likely MLH3 confer an increased colorectal cancer risk through somatic second hits, inducing hypermutant, microsatellite-stable tumors characterized by signature ID4 and excess somatic deletions.